Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis.

van Es MA, Schelhaas HJ, van Vught PW, Ticozzi N, Andersen PM, Groen EJ, Schulte C, Blauw HM, Koppers M, Diekstra FP, Fumoto K, LeClerc AL, Keagle P, Bloem BR, Scheffer H, van Nuenen BF, van Blitterswijk M, van Rheenen W, Wills AM, Lowe PP, Hu GF, Yu W, Kishikawa H, Wu D, Folkerth RD, Mariani C, Goldwurm S, Pezzoli G, Van Damme P, Lemmens R, Dahlberg C, Birve A, Fernández-Santiago R, Waibel S, Klein C, Weber M, van der Kooi AJ, de Visser M, Verbaan D, van Hilten JJ, Heutink P, Hennekam EA, Cuppen E, Berg D, Brown RH Jr, Silani V, Gasser T, Ludolph AC, Robberecht W, Ophoff RA, Veldink JH, Pasterkamp RJ, de Bakker PI, Landers JE, van de Warrenburg BP, van den Berg LH.

Ann Neurol. 2011 Dec;70(6):964-73. doi: 10.1002/ana.22611. Review.

2.

Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Kishikawa H, Wu D, Hu GF.

Expert Opin Ther Targets. 2008 Oct;12(10):1229-42. doi: 10.1517/14728222.12.10.1229 . Review.

3.

Lack of association between the Angiogenin (ANG) rs11701 polymorphism and amyotrophic lateral sclerosis risk: a meta-analysis.

Pan LS, Deng XB, Wang Z, Leng HL, Zhu XP, Ding D.

Neurol Sci. 2016 May;37(5):655-62. doi: 10.1007/s10072-015-2473-x. Epub 2016 Jan 11. Review.

PMID:
26753798
4.

Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

D'Amico E, Factor-Litvak P, Santella RM, Mitsumoto H.

Free Radic Biol Med. 2013 Dec;65:509-27. doi: 10.1016/j.freeradbiomed.2013.06.029. Epub 2013 Jun 21. Review.

5.

Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.

Saberi S, Stauffer JE, Schulte DJ, Ravits J.

Neurol Clin. 2015 Nov;33(4):855-76. doi: 10.1016/j.ncl.2015.07.012. Review.

Supplemental Content

Support Center